BBJ: Investment Firms See One-Day Loss of $1.7B in Biogen's Alzheimer's Drug

Life Sciences Reporter Allison DeAngelis joins necn to discuss her story, “ Mass. investment firms see one-day loss of $1.7B in Biogen’s Alzheimer’s drug flop.”